Table 1

Average and incremental costs (Australian $) from the EPIC trial

Event	Average cost, placebo	Average cost, abciximab	Incremental cost
Single PTCA	4164	4189	25
Received abciximab	0	1633	1633
CABG during initial hosp	571	466	−105
Repeat PTCA during hosp	271	156	−116
Death during initial hosp	9	7	−2
MI during initial hosp	57	31	−26
Stent during initial hosp	22	22	0
IABP during initial hosp	133	106	−27
Minor bleeding	20	34	14
Transfusions	65	143	78
CABG post initial hosp	623	509	−114
PTCA post initial hosp	719	535	−184
Death post initial hosp	118	101	−16
MI post initial hosp	28	21	−7
CHF post initial hosp	56	14	−42
Unstable angina post initial hosp	109	52	−57

Total	$6965	$8019	$1054

CABG, coronary artery bypass grafting; CHF, chronic heart failure; hosp, hospital admission; IABP, intra-aortic balloon pump; MI, myocardial infarction; PTCA, percutaneous transluminal coronary angioplasty.